Journal

Adipocyte
ISSN: 2162-397X
Titre abrégé: Adipocyte
Pays: United States
ID NLM: 101567863

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 17 7 2021
Statut: ppublish

Résumé

Hyperinsulinemia is the hallmark of the development of insulin resistance and precedes the diagnosis of type 2 diabetes. Here we evaluated the effects of prolonged exposure (≥4 days) to high insulin doses (150 nM)

Identifiants

pubmed: 32718202
doi: 10.1080/21623945.2020.1798613
pmc: PMC7469436
doi:

Substances chimiques

Adiponectin 0
Biomarkers 0
Insulin 0
Insulin Receptor Substrate Proteins 0
Irs1 protein, mouse 0
Receptor, Insulin EC 2.7.10.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-426

Références

Endocrinology. 1997 Oct;138(10):4338-45
pubmed: 9322948
Int J Mol Sci. 2016 Jun 30;17(7):
pubmed: 27376273
Biochimie. 2016 Jun;125:259-66
pubmed: 26542285
Diabetes Care. 2008 Feb;31 Suppl 2:S262-8
pubmed: 18227495
Obes Facts. 2008;1(4):184-9
pubmed: 20054179
J Biol Chem. 2015 May 1;290(18):11337-48
pubmed: 25720492
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7569-74
pubmed: 12808134
Am J Physiol. 1978 Jul;235(1):E53-62
pubmed: 677310
Mol Cell. 1999 Feb;3(2):151-8
pubmed: 10078198
Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15
pubmed: 11244452
Cell Rep. 2013 Oct 17;5(1):259-70
pubmed: 24095730
J Biol Chem. 1991 Jun 25;266(18):11726-31
pubmed: 2050674
Diabetologia. 1985 Feb;28(2):70-5
pubmed: 3884419
Am J Physiol. 1998 May;274(5):R1253-9
pubmed: 9644037
Diabetes. 2019 Aug;68(8):1565-1576
pubmed: 31092478
FEBS Lett. 2008 Jan 9;582(1):97-105
pubmed: 18053812
Nat Med. 2007 Oct;13(10):1193-202
pubmed: 17906635
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10162-7
pubmed: 21646544
Nat Commun. 2015 Jun 29;6:7433
pubmed: 26118629
J Biol Chem. 2013 Apr 5;288(14):9867-9880
pubmed: 23400783
Proc Natl Acad Sci U S A. 1974 Jan;71(1):84-8
pubmed: 4359334
PLoS One. 2014 Sep 26;9(9):e108693
pubmed: 25259572
Diabetes Obes Metab. 2006 May;8(3):264-80
pubmed: 16634986
J Biol Chem. 1997 Apr 18;272(16):10585-93
pubmed: 9099705
Diabetologia. 2006 Sep;49(9):2162-73
pubmed: 16865359
Sci Rep. 2017 Jun 22;7(1):4031
pubmed: 28642596
J Histochem Cytochem. 2014 Dec;62(12):889-901
pubmed: 25246387
Biochem J. 2004 Dec 1;384(Pt 2):349-55
pubmed: 15307820
Elife. 2017 Jun 07;6:
pubmed: 28589878
J Biol Chem. 1997 Mar 21;272(12):7759-64
pubmed: 9065437
Diabetes. 2013 Sep;62(9):3163-9
pubmed: 23670973
Diabetes. 1996 Nov;45(11):1644-54
pubmed: 8866574
Mol Metab. 2014 Mar 12;3(4):408-18
pubmed: 24944900
Diabetes. 2017 Apr;66(4):815-822
pubmed: 28052966
Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E537-46
pubmed: 15126243
Anal Biochem. 2012 Jun 1;425(1):88-90
pubmed: 22425542
Lipids Health Dis. 2015 Sep 29;14:121
pubmed: 26415887

Auteurs

A Rossi (A)

Bioscience Metabolism, Research And Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.

M Eid (M)

Bioscience Metabolism, Research And Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.

J Dodgson (J)

Biologics Therapeutics, Antibody and Protein Engineering, R&D, AstraZeneca , Cambridge, UK.

G Davies (G)

Bioscience Metabolism, Research And Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.

B Musial (B)

Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.

M Wabitsch (M)

Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University Medical Center , Ulm, Germany.

C Church (C)

Bioscience Metabolism, Research And Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.

D C Hornigold (DC)

Bioscience Metabolism, Research And Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca , Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH